Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesCardiologyKaiser Permanente Wearable Defibrillator Prior Aut…
    Ask Trek AI about this page
    ModifiedKaiser PermanentePolicy N/A

    Wearable_Auto_Defibrillator

    Customize your policy alerts

    Sign up for all Kaiser Permanente policy alerts

    Know when Kaiser Permanente releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Clinical review criteria for automated external defibrillators (AEDs) for home use in pediatric patients and wearable cardioverter defibrillators (WCD/WAD) for adults, including coverage guidance, background, evidence conclusions, applicable HCPCS codes, and a revision reinstating prior authorization for non‑Medicare members effective 2026-08-01.

    Policy Summary
    PayerKaiser Permanente
    PolicyWearable_Auto_Defibrillator
    Policy CodePolicy N/A
    Change TypeReinstated prior authorizationadopt Medicare LCD guidance
    Effective DateApr 19, 2007
    Last ReviewMar 3, 2026
    Next Review DateN/A
    Key ActionEffective 2026-08-01, prior authorization is required for wearable automatic defibrillators for non‑Medicare members identified as high risk of sudden cardiac death; prescribing practitioners must have relevant clinical experience.
    SourceLink
    POLICY UPDATE CHANGES

    03/03/2026 MPC approved reinstating prior authorization for WADs for non‑Medicare members at high risk of sudden cardiac death, requiring prescribing practitioners to have relevant clinical experience; 60‑day notice required, effective 08/01/2026.

    Policy notes that Kaiser will use Medicare LCD L33690 and Coverage Article A52458 for non‑Medicare members effective August 1, 2026.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    2Device types discussed (WCD and pediatric AED)
    5HCPCS codes listed
    1Material policy change (PA reinstated)

    Coverage Summary

    This policy provides clinical review criteria for wearable cardioverter defibrillators (WCD/WAD) for adults and automated external defibrillators (AEDs) for home use in pediatric patients. Coverage stance is mixed: the policy documents clinical guidance and references Medicare LCD/Local Coverage Article for Medicare members while noting insufficient evidence for routine effectiveness of these devices.

    Effective date: 2007-04-19. Last review: 2026-03-03. There is a material policy change: on 03/03/2026 the Medical Policy Committee approved reinstating prior authorization (PA) for WADs for non‑Medicare members identified as high risk of sudden cardiac death and requiring prescribing practitioners to have relevant clinical experience; this change requires 60 days’ notice and is effective 08/01/2026.

    Key policy facts
    effective date2007-04-19
    last review2026-03-03
    policy statusMODIFIED
    scope_summaryClinical review criteria for home use automated external defibrillators (pediatric) and wearable cardioverter defibrillators (WCD/WAD) for adults, including coverage guidance, background, evidence conclusions, applicable HCPCS codes, and a reinstated prior authorization for non‑Medicare WADs effective 2026-08-01.
    has_material_changetrue (03/03/2026 MPC approved reinstating prior authorization for WADs for non‑Medicare members; 60-day notice; effective 08/01/2026)

    Medical-Necessity Criteria

    Medicare Members / Non‑Medicare Members Guidance

    Policy references Medicare LCD and Coverage Article for Medicare members; non‑Medicare members follow policy until 2026-08-01 and thereafter adopt Medicare LCD guidance with reinstated prior authorization for WADs for non‑Medicare members.

    • Medicare members: For Medicare members: Kaiser uses applicable policy sources; Local Coverage Determination (L33690) and Local Coverage Article (A52458) apply

      Medicare members follow CMS LCD/A

    • Non‑Medicare members (until 2026-08-01): For non‑Medicare members: Existing Automatic External Defibrillators criteria effective until 2026-08-01; effective August 1, 2026 Kaiser will use coverage guidance from Medicare's LCD (L33690) and Coverage Article (A52458)

      Change effective 2026-08-01

    • Prior authorization reinstatement (non‑Medicare): 03/03/2026 MPC approved reinstating prior authorization for WADs for non‑Medicare members at high risk of sudden cardiac death, with prescribing practitioners required to have relevant clinical experience

    Provider Actions & Requirements

    Prior Authorization

    Prior authorization reinstated for WADs (non‑Medicare members)

    Effective 2026-08-01, prior authorization is required for wearable automatic defibrillators for non‑Medicare members identified as high risk of sudden cardiac death; prescribing practitioners must have relevant clinical experience.

    • Affected HCPCS/HCPC codes: K0606, K0607, K0608, K0609, E0617
    • Effective date: 2026-08-01
    • Prescribing practitioner must have relevant clinical experience (practitioner experience requirement reinstated)
    Documentation Required

    Follow Medicare LCD/Local Coverage Article for Medicare members

    For Medicare members, coverage follows LCD L33690 and Article A52458; providers should reference those documents and supply required documentation per CMS guidance when submitting claims.

    Coding

    Medical Necessity Review not required (Applicable HCPCS)HCPCS
    E0617External defibrillator with integrated electrocardiogram analysis
    K0606Automatic external defibrillator, with integrated electrocardiogram analysis, garment type
    K0607Replacement battery for automated external defibrillator, garment type only, each
    K0608Replacement garment for use with automated external defibrillator, each
    K0609Replacement electrodes for use with automated external defibrillator, garment type only, each

    Background, Evidence, and Definitions

    Background materials describe sudden cardiac death (SCD) and the evolution of defibrillation devices from implantable cardioverter defibrillators (ICDs) to external options. Two device types are discussed: the automated external defibrillator with integrated ECG analysis that requires an operator to shock, and the wearable cardioverter defibrillator (WCD/WAD), a vestlike garment that continuously monitors rhythm and can automatically deliver shocks without bystander intervention. The LIFECOR WCD2000 is FDA‑cleared for 24‑hour use in patients at risk of sudden cardiac arrest when an implantable ICD is unwanted or impractical, and the FDA specifies contraindications (e.g., age <18 years, pregnancy, presence or need for an ICD, inability/unwillingness to wear continuously, sensory or medication limitations that would prevent use of the response buttons).

    Evidence reviews summarized in the policy conclude insufficient evidence of efficacy and safety. The Kaiser Medical Technology Assessment found only small observational studies (the largest being WEARIT/BIROAD) and determined the published studies do not provide sufficient evidence to establish that wearable automatic defibrillators prevent sudden cardiac death. Similarly, for pediatric use the Heartstream FR2 (FDA‑approved with attenuated pads for children ≤8 years or ≤55 lbs) has accuracy data but no evidence showing reduced mortality in home or school settings; Kaiser concluded AED use in the home for pediatric patients does not meet Medical Technology Assessment criteria.

    StudyKey takeaway
    WEARIT/BIROAD (Feldman et al.)Largest observational study of wearable defibrillators; evidence insufficient to determine efficacy and safety
    Cecchin et al. 2001 (Heartstream FR2 detection accuracy)Study suggests accurate arrhythmia detection in children but did not evaluate delivered shock appropriateness or mortality outcomes

    Definitions: A Wearable Cardioverter Defibrillator / Wearable Automatic Defibrillator (WCD/WAD) is a vestlike external defibrillator with integrated electrocardiogram analysis designed to monitor rhythm and automatically deliver a shock if the patient becomes unconscious.

    An Automated External Defibrillator (AED) is a portable device that analyzes heart rhythms and delivers shocks when indicated. The Heartstream FR2 is an AED model with pediatric‑attenuated pads specifically intended for children ≤8 years old or weighing ≤55 pounds.

    Medicare Determinations

    Document Type / NumberTitle
    L33690 (LCD)Automatic External Defibrillators
    A52458 (Local Coverage Article)Automatic External Defibrillators

    Revision History

    03/03/2026policy_revisionLatest

    MPC approved reinstating prior authorization for wearable automatic defibrillators (WADs) for non‑Medicare members identified as high risk of sudden cardiac death, requiring prescribing practitioners to have relevant clinical experience; 60‑day notice required, effective 08/01/2026.

    08/01/2026policy_effective_date

    Effective August 1, 2026 Kaiser Permanente will use Medicare's Local Coverage Determination (L33690) and Coverage Article (A52458) guidance for non‑Medicare members regarding Automatic External Defibrillators and wearable automatic defibrillators.

    2007-04-19
    Policy Summary
    PayerKaiser Permanente
    PolicyWearable_Auto_Defibrillator
    Policy CodePolicy N/A
    Change TypeReinstated prior authorizationadopt Medicare LCD guidance
    Effective DateApr 19, 2007
    Last ReviewMar 3, 2026
    Next Review DateN/A
    Key ActionEffective 2026-08-01, prior authorization is required for wearable automatic defibrillators for non‑Medicare members identified as high risk of sudden cardiac death; prescribing practitioners must have relevant clinical experience.
    SourceLink
    On This Page
    Coverage SummaryMedical-Necessity CriteriaProvider Actions & RequirementsCodingBackground, Evidence, and DefinitionsMedicare DeterminationsRevision History

    60‑day notice; effective 2026-08-01

    Medical Necessity / Evidence Conclusions

    Coverage determinations informed by evidence summaries and technology assessment

    • WCD/WAD evidence conclusion: Use of Wearable Automatic Defibrillators (WCD/WAD) does not meet Kaiser Permanente Medical Technology Assessment Criteria (insufficient evidence of efficacy and safety)

      Evidence: observational studies, small sample sizes; WEARIT/BIROAD largest study

    • Pediatric AED evidence conclusion: Use of AED in the home to prevent sudden death from ventricular fibrillation in pediatric patients does not meet Kaiser Permanente Medical Technology Assessment Criteria (insufficient evidence of mortality benefit)

      Limited pediatric evidence; Heartstream FR2 detection accuracy study exists but no clinical outcomes

    FDA/Device Contraindications (Background Operational Criteria)

    FDA‑stated contraindications and practical limitations for WCD

    • Implantable ICD: Do NOT use WCD if patient has or needs an implantable ICD
    • Age: Do NOT use WCD in patients under 18 years of age
    • Pregnancy/Breastfeeding: Do NOT use WCD in pregnant or breastfeeding patients
    • Vision/Hearing/Medication interference: Do NOT use WCD in patients with vision or hearing problems or taking medications that would interfere with pushing response button on alarm module
    • Willingness/Ability to wear: Do NOT use WCD in patients unwilling or unable to wear device continuously
    • Childbearing not preventing pregnancy: Do NOT use WCD in patients of childbearing age not attempting to prevent pregnancy
    • EMI exposure: Do NOT use WCD if patient is exposed to excessive electromagnetic interference
  1. Reference: Medicare Local Coverage Determination (L33690) and Local Coverage Article (A52458)
  2. Providers must supply required CMS documentation when submitting claims
  3. policy_created

    Clinical Review Criteria for Automatic External Defibrillators originally effective; background, device descriptions, FDA indications, evidence conclusions, and applicable HCPCS codes documented.